Press release
Liver Disease Therapeutics Market to Reach USD 34.78 Billion by 2030, Growing at a 7.4% CAGR
Liver Disease Therapeutics Market
The liver disease therapeutics market was valued at USD 21.10 billion in 2023 and is projected to reach USD 34.78 billion by 2030, growing at a CAGR of 7.4% during the forecast period (2024-2030). Innovations in therapeutics and increased awareness about liver health are driving the market forward.
The global liver disease therapeutics market is experiencing significant growth, fueled by rising cases of liver diseases and advancements in medical treatments. This press release delves into the market's CAGR details, market size, key country-specific data, and major developments, providing a comprehensive analysis for stakeholders.
๐๐จ ๐ฅ๐๐๐ซ๐ง ๐ฆ๐จ๐ซ๐, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/229296/
Country-Specific Analysis
๐๐ข๐๐ญ๐ง๐๐ฆ: ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ข๐ง ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ
Vietnam is witnessing an increase in investments in healthcare infrastructure. Recent acquisitions by Pharmacity and collaborations with local biotech firms are paving the way for advanced liver disease therapies. The market in Vietnam is poised for steady growth, driven by government initiatives.
๐๐ก๐๐ข๐ฅ๐๐ง๐: ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐ซ๐จ๐ฐ๐ญ๐ก
Thailand's market for liver disease treatments is growing due to a surge in non-alcoholic fatty liver disease (NAFLD) cases. Companies like Bangkok Dusit Medical Services are actively expanding their research and treatment facilities, making significant contributions to market consolidation.
๐๐๐ฉ๐๐ง: ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ
Japan's advancements in regenerative medicine are influencing the liver disease therapeutics market. Collaborations between firms like Takeda Pharmaceutical and research institutions are accelerating innovations in treatments for chronic liver diseases.
๐๐จ ๐ฅ๐๐๐ซ๐ง ๐ฆ๐จ๐ซ๐, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/229296/
๐๐ก๐ข๐ง๐: ๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ
China dominates the liver disease therapeutics market in Asia, thanks to a strong focus on biotechnology and pharmaceutical developments. Major players such as Sinopharm are investing in R&D, driving significant market consolidation.
๐๐จ๐ฎ๐ญ๐ก ๐๐จ๐ซ๐๐: ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐ฉ๐๐๐ญ๐ข๐จ๐ง
South Korea is rapidly adopting cutting-edge technologies in liver therapeutics. Companies like Celltrion are leading clinical trials for advanced treatments, emphasizing biopharmaceutical solutions.
๐๐ข๐ง๐ ๐๐ฉ๐จ๐ซ๐: ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ
Singapore's robust healthcare ecosystem supports the growth of liver disease treatments. With firms like Singapore Biotech spearheading research in novel therapies, the market continues to attract global investors.
๐๐จ ๐ฅ๐๐๐ซ๐ง ๐ฆ๐จ๐ซ๐, ๐ฌ๐ข๐ฆ๐ฉ๐ฅ๐ฒ ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค :https://www.maximizemarketresearch.com/request-sample/229296/
๐๐: ๐๐ซ๐๐ง๐๐ฌ ๐๐ง๐ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ
The US remains a leader in the liver disease therapeutics market, with significant investments in clinical trials. Companies like Gilead Sciences and AbbVie are advancing the development of therapies for hepatitis and cirrhosis, ensuring consistent market growth.
๐๐ฎ๐ซ๐จ๐ฉ๐: ๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ซ๐๐ง๐๐ฌ ๐ข๐ง ๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ
Europe's liver disease therapeutics market is characterized by strategic mergers and acquisitions. Firms like Sanofi and Novartis are focusing on precision medicine, while collaborations with academic institutions drive innovation.
๐๐๐ฒ ๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
Gilead Sciences expanded its clinical trials for hepatitis C treatments in 2024, enhancing its pipeline portfolio.
AbbVie announced its partnership with European research centers to develop novel treatments for liver fibrosis.
Sinopharm launched a new biosimilar drug targeting liver diseases, strengthening its foothold in the Asia-Pacific region.
Takeda Pharmaceutical introduced its latest drug for autoimmune liver disorders in the Japanese market.
Celltrion completed Phase III trials for a breakthrough treatment targeting non-alcoholic steatohepatitis (NASH).
๐ ๐จ๐ซ ๐ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐จ๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ฅ๐ข๐๐ค ๐จ๐ง ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐๐:https://www.maximizemarketresearch.com/market-report/liver-disease-therapeutics-market/229296/
๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
๐๐ฒ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐ฒ๐ฉ๐
Antiviral Drugs
Immunosuppressant
Vaccines
Immunoglobulin
Corticosteroids
Targeted Therapy
Chemotherapy
๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ฒ๐ฉ๐
Hepatitis
Autoimmune Diseases
Non-alcoholic Fatty Liver Disease (NAFLD)
Cancer
Genetic Disorders
๐๐ข๐ฏ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
1. Johnson & Johnson Services Inc.
2. F. Hoffmann-La Roche Ltd.
3. Pfizer Inc.
4. Abbott Laboratories
5. Novartis AG
6. Eli Lilly and Company
7. Gilead Sciences
8. Bristol Myers Squibb
9. AbbVie Inc.
10. Zydus Pharmaceuticals Inc.
11. Intercept Pharmaceuticals, Inc.
12. Merck & Co., Inc.
13. Bristol-Myers Squibb Company
14. Johnson & Johnson
15. Takeda Pharmaceutical Company Limited
16. Eli Lilly and Company
17. Astellas Pharma Inc., Bristol-Myers Squibb
18. GlaxoSmithKline Plc,
19. Merck & Co. Inc.
20. Sanofi S.A
21. Takeda Pharmaceutical
22. Valeant Pharmaceuticals
23. Watson Pharmaceuticals Inc.
24. Theratechnologies Inc.
25. Alnylam Pharmaceuticals Inc.
26. Protagonist Therapeutics Inc.
27. Dicerna Pharmaceuticals Inc.
28. Endo International
29. Provectus Biopharmaceuticals Inc.
30. MAX BioPharma Inc.
31. Achillion Pharmaceuticals
32. Actavis Pharma Inc
33. Alkermes Plc
34. Antipodean Pharmaceuticals
35. Bayer Healthcare Pharmaceuticals
36. Biotest Pharma GmbH
37. Bristol-Myers Squibb Company
38. Conatus Pharmaceuticals
๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ ๐๐ก๐๐ญ'๐ฌ ๐๐ซ๐๐ง๐๐ข๐ง๐ :
โฆ Hose Reel Market https://www.maximizemarketresearch.com/market-report/hose-reel-market/78645/
โฆ Ice Cream Machine Market https://www.maximizemarketresearch.com/market-report/ice-cream-machine-market/78649/
โฆ Industrial Automation Oil Gas Market https://www.maximizemarketresearch.com/market-report/industrial-automation-oil-gas-market/152501/
โฆ Industrial Grippers Market https://www.maximizemarketresearch.com/market-report/industrial-grippers-market/77933/
โฆ Industrial Palletizing Robots Market https://www.maximizemarketresearch.com/market-report/industrial-palletizing-robots-market/77409/
โฆ Marine Fire Fighting Equipment Market https://www.maximizemarketresearch.com/market-report/marine-fire-fighting-equipment-market/76737/
โฆ Orbital Sanders Market https://www.maximizemarketresearch.com/market-report/orbital-sanders-market/75450/
โฆ Personal Safety Alarms Market https://www.maximizemarketresearch.com/market-report/personal-safety-alarms-market/148479/
โฆ Photodynamic Therapy Market https://www.maximizemarketresearch.com/market-report/photodynamic-therapy-market/45186/
โฆ Plug Valve Market https://www.maximizemarketresearch.com/market-report/plug-valve-market/78257/
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
๐๐๐จ๐ฎ๐ญ ๐๐๐ฑ๐ข๐ฆ๐ข๐ณ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liver Disease Therapeutics Market to Reach USD 34.78 Billion by 2030, Growing at a 7.4% CAGR here
News-ID: 3822345 • Views: โฆ
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
Candle Market to Reach USD 18.39 Billion by 2032, Growing at 8.2% CAGR - Driven โฆ
The global candle market is projected to nearly double in value by 2032, supported by rising interest in home aesthetics, aromatherapy, and eco-friendly lifestyle products.
Opening Paragraph
According to a recent market analysis, the global candle market was valued at USD 9.79 billion in 2024 and is forecast to reach USD 18.39 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032. Growth is fueledโฆ
Microalgae-Based Products Market to Reach USD 23.01 Billion by 2030, Growing at โฆ
The global microalgae-based products market is projected to grow significantly through 2030, driven by the rising use of microalgae in nutraceuticals, natural food colorants, cosmetics, and sustainable bio-based applications.
Opening Paragraph
According to a new market analysis, the global microalgae-based products market was valued at approximately USD 13.25 billion in 2023 and is expected to reach USD 23.01 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.2% duringโฆ
Bicycle Market to Reach USD 163.51 Billion by 2032, Growing at 9.8% CAGR - Risin โฆ
The global bicycle market is projected to grow robustly through 2032, propelled by the surging popularity of electric bicycles (e-bikes), government initiatives for sustainable transport, and rising health and fitness awareness.
Opening Paragraph
According to a recent industry analysis, the global bicycle market was valued at approximately USD 77.40 billion in 2024 and is expected to reach USD 163.51 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.8%โฆ
Courier Services Market to Reach USD 712.07 Billion by 2032 at 5.8% CAGR - Globa โฆ
Courier Services Market to Reach USD 712.07 Billion by 2032 at 5.8% CAGR - Strong Growth Driven by E-Commerce Expansion
Subheading:
The global courier services market is projected to achieve steady growth through 2032, fueled by surging e-commerce activity, rapid digitalization, and increased cross-border trade.
Unlock more insights-request a free sample report now : https://www.maximizemarketresearch.com/request-sample/168771/
Opening Paragraph:
According to a new industry report, the global courier services market was valued at USD 453.56 billion inโฆ
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โฆ
๐๐๐, ๐๐๐ฐ ๐๐๐ซ๐ฌ๐๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoringโฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโฆ
